Lumos Diagnostics Quote - LDX

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

0.031

Bid

0.03

Ask

0.032

Volume

1,647,602

0.03 Day's Range 0.031

0.028 52 Week Range 0.1075

Market Cap

14.921M

Previous Close

0.03

Open

0.03

Last Trade

0.031

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

3,498,493

Shares Outstanding

481,306,899

Dividend Yield

PE Ratio

-1.68

Earnings Per Share (EPS)

-0.02

Revenue

11.13M

Net Profit

-8.59M

Sector

In Vitro,in Vivo Diagnostics

Industry

In Vitro,in Vivo Diagnostics

Website

lumosdiagnostics.com

Headquarters

Melbourne, Victoria, Aus

Founded

Lumos Diagnostics Holdings Ltd is listed in the In Vitro,in Vivo Diagnostics sector of the Australian Stock Exchange with ticker LDX. The last closing price for Lumos Diagnostics was AUD0.03. Over the last year, Lumos Diagnostics shares have traded in a share price range of AUD 0.028 to AUD 0.1075.

Lumos Diagnostics currently has 481,306,899 shares outstanding. The market capitalization of Lumos Diagnostics is AUD14.44 million. Lumos Diagnostics has a price to earnings ratio (PE ratio) of -1.68.

Lumos Diagnostics Appoints Doug Ward as CEO

SARASOTA, Fla., June 21, 2022 (GLOBE NEWSWIRE) -- Lumos Diagnostics (ASX:LDX), a leader in rapid point-of-care (POC) diagnostic technologies, announced today that its Board of Directors has...

Lumos Diagnostics Receives Authorization for CoviDx™ SARS-CoV-2 Rapid Antigen Test in Canada

Lumos Diagnostics (ASX: LDX), a leader in rapid point-of-care (POC) diagnostic technologies, today announced that Health Canada has granted Interim Order authorization for the Lumos CoviDx™...

Economic Evaluation of Lumos Diagnostics’ FebriDx® Point-of-Care Test Highlights $2.5 Billion in Potential U.S. Healthcare Cost Savings Annually

Journal of Health Economics and Outcomes Research Publishes Cost Impact of the Novel, Rapid Point-of-Care Test Lumos Diagnostics (ASX: LDX), a leader in rapid point-of-care (POC) diagnostic...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.005	-13.8888888889	0.036	0.036	0.03	2630230	0.03227008	DE
4	-0.003	-8.82352941176	0.034	0.037	0.03	1905721	0.03213188	DE
12	-0.012	-27.9069767442	0.043	0.049	0.03	3498493	0.03612997	DE
26	-0.004	-11.4285714286	0.035	0.054	0.028	2810052	0.03783908	DE
52	-0.034	-52.3076923077	0.065	0.1075	0.028	3799896	0.06237931	DE
156	-0.794	-96.2424242424	0.825	1.265	0.01	4193907	0.0844108	DE
260	-1.469	-97.9333333333	1.5	1.5	0.01	3699521	0.09511607	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
IVXInvion Ltd	AUD 0.15 (7,400.00%)	29.48k
PPGPro Pac Packaging Limited	AUD 0.042 (147.06%)	2.8M
TVNOTivan Ltd	AUD 0.012 (100.00%)	42.5k
ATHOAlterity Therapeutics Limited	AUD 0.002 (100.00%)	2.75M
IPTOImpact Minerals Ltd	AUD 0.002 (100.00%)	500k
ARUOAArafura Rare Earths Ltd	AUD 0.006 (-45.45%)	1.05M
LRDOLord Resources Ltd	AUD 0.006 (-40.00%)	3.33k
HIQOHitIQ Limited	AUD 0.01 (-33.33%)	20k
EXLElixinol Wellness Limited	AUD 0.004 (-33.33%)	475.41k
JAVJavelin Minerals Ltd	AUD 0.003 (-25.00%)	20.21M
MMIMetro Mining Ltd	AUD 0.063 (6.78%)	872.16M
OVTOvanti Ltd	AUD 0.023 (-14.81%)	78.61M
ATHAlterity Therapeutics Ltd	AUD 0.005 (25.00%)	64.44M
SYASayona Mining Limited	AUD 0.031 (-3.13%)	54.63M
RDNRaiden Resources Limited	AUD 0.015 (-11.76%)	49.91M

Juntao 4 minutes ago

$AUTR
https://www.stockscores.com/chart.asp?TickerSymbol=AUTR&TimeRange=1095&Interval=w&Volume=1&ChartType=CandleStick&Stockscores=1&ChartWidth=1100&ChartHeight=480&LogScale=&Band=&avgType1=&movAvg1=&avgType2=&movAvg2=&Indicator1=None&Indicator2=None&Indicator3=None&Indicator4=None&endDate=&C

AUTR

Juntao 5 minutes ago

AUTR

Juntao 7 minutes ago

AUTR

shajandr 9 minutes ago

To Whom It May CONcern: MGTI is nuffin butt a LADD/HONIG/FIFE scam.

MGTI

biosectinvestor 12 minutes ago

Ah; you're just talking off label for an already approved oncology drug.

You seem to forget that the 21st Century Cures Act is all about making those drugs not just broadly available to a broader array of patients and conditions asap, but also getting insurance coverage even if the dr

NWBO

biosectinvestor 14 minutes ago

This is not true. Too many people I know go for experimental treatments overseas including people I know really can't afford it but somehow get the money together and most of those treatments are untried and a waste of money. I have known too many people who, being diagnosed with serious, life threa

NWBO

devil dog 96 15 minutes ago

The shares I got on the BID @ .30 were sold when we got the freak bonus POP to 98 cents in 2020. I started reloading after the bear raid started. My average is under .06 now because I was smart enough to BID sit the past year and collect what ever shares you no proof scam theory promoter clowns

ATMH

jeunke22 28 minutes ago

You are correct. Apparently a double count put it at 44 mio in the Fintel reporting early November, but it was corrected to 40 mio. Up from 33,7 mio per 09/30 to 40 mio as of November.

LWLG

infamous 35 minutes ago

Right

SFIO

Richie R 36 minutes ago

Looking for a winner here!

nowwhat2 39 minutes ago

https://investorshub.advfn.com/uimage/uploads/2024/12/1/oozwgXRP_111111_30_5d_730pm_news_event_Q_TA.jpg

https://investorshub.advfn.com/uimage/uploads/2024/12/1/nszyaXRP_111111_30_5d_10pm_news_event_Q_TA.jpg

5 HOURS EARLIER ;

XRPUSD

cash-talks-bs-walks 48 minutes ago

Time to make some $$$$$$$

PGHL

cb521 50 minutes ago

In His Time. Very excited at what’s happening, not hoping for anything. Chilling

ZNOG

CorsairNavigator20 56 minutes ago

Just my thoughts are the phase 1 data could drive us to $250M. Phase2 would not be completed in 2025 and I would be hoping 500-750M. The real driver would be the pancreatic cancer study next year. That phase 1 data could drive it since the study group could have 3-6 months to end of life. I look

MRKR

nowwhat2 1 hour ago

You LIKE our new CEO ?.....I dunno.....
I had to fix her hair ;
https://www.news-journal.com/international-battery-metals-ibat-announces-iris-jancik-takes-helm-as-ceo-to-lead-expansion-of/article_3a9f211a-8b57-5c12-beb5-d202cf389a6a.html

https://investorshub.advfn.com/

IBATF

RichieBoy 1 hour ago

Are you trying to establish the premise that OTCN has stopped screwing over Retail. Or is this pure speculation. 🤹

AFFU

XMaster2023 1 hour ago

RobotDroid,
Speaking of GIGO, you win.

NWBO

FrostyStar1 1 hour ago

Well lets see, the only time Ukraine didn't get smaller was when Trump was in the White House. Obama gave Putin Crimea and Biden let Putin take Eastern Ukraine.

The only time North Korea wasn't firing off rockets was when Trump was president.

Biden abandoned 11 embassi

STHC

	Real-time Prices	Level 2
Toronto Stock Exchange
Toronto Stock Exchange Venture Exchange

	Real-time Prices	Level 2
Dow Jones Indices
Toronto Stock Exchange
Toronto Stock Exchange Venture Exchange
OTCBB
New York Stock Exchange
NASDAQ
American Stock Exchange
OTCMarkets
Canadian Securities Exchange
OPRA
OPRA Indices
Forex

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

Lumos Diagnostics Holdings Ltd (LDX)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

About Lumos Diagnostics Holdings Ltd

Ask ADVFN Intelligence (AI)

LDX Latest News

Lumos Diagnostics Appoints Doug Ward as CEO

Lumos Diagnostics Receives Authorization for CoviDx™ SARS-CoV-2 Rapid Antigen Test in Canada

Economic Evaluation of Lumos Diagnostics’ FebriDx® Point-of-Care Test Highlights $2.5 Billion in Potential U.S. Healthcare Cost Savings Annually

Dr. Jerome Adams, Former U.S. Surgeon General, Joins Lumos Diagnostics as a Strategic Healthcare Adviser

Lumos Diagnostics FY21 Full Year Results

Lumos Diagnostics Raises $63M AUD in ASX IPO

Movers

Discussion

Your Recent History

Company

Business

Popular

Get The App

BLACK FRIDAY

Save up to 60%* for Canada: TSX and TSXV Level 1

1 year 40%, 2 years 40% and *3 years 60%

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

Lumos Diagnostics Holdings Ltd (LDX) Share Price

Lumos Diagnostics Holdings Ltd (LDX)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

About Lumos Diagnostics Holdings Ltd

Ask ADVFN Intelligence (AI)

LDX Latest News

Lumos Diagnostics Appoints Doug Ward as CEO

Lumos Diagnostics Receives Authorization for CoviDx™ SARS-CoV-2 Rapid Antigen Test in Canada

Economic Evaluation of Lumos Diagnostics’ FebriDx® Point-of-Care Test Highlights $2.5 Billion in Potential U.S. Healthcare Cost Savings Annually

Dr. Jerome Adams, Former U.S. Surgeon General, Joins Lumos Diagnostics as a Strategic Healthcare Adviser

Lumos Diagnostics FY21 Full Year Results

Lumos Diagnostics Raises $63M AUD in ASX IPO

Movers

Discussion

Your Recent History

Company

Business

Popular

Get The App

BLACK FRIDAY

Save up to 60%* for North American Extreme

1 year 40%, 2 years 40% and *3 years 60%